Clinical information
Diagnostic Utility:
This test is used to determine the presence or absence of the Jka antigen on red blood cells. It is part of the red cell phenotype study. It is also useful in the study of the specificity of irregular antibodies to demonstrate that in the presence of an anti-Jka specificity, the person who has developed the antibody is Jka negative.
Method:
Hemagglutination.
Reference Values
The possible results are: Negative, Positive.
In cases where the result is doubtful, for example due to recent transfusions, this is reported and the need for complementary studies to unequivocally determine the Jka phenotype is indicated.
Diagnostic Algorithm:
Not applicable.
Turnaround Time:
1 day.
Specimen information
Sample: Whole Blood
Tube: EDTA K3 10 ml Tube
Minimum volume: 6 ml
Stability:
- At room temperature: 2 days
- In refrigeration: 2 days
Transport instructions: Preferably at room temperature
Reason for rejection: Highly hemolyzed sample
Administrative information
BST Code: 0530
Test Description: Jka antigen phenotype
Synonyms: Ag Jka
Section: Immunohematology
BST Rate: Check the updated rates here.
Profiles:
Test 0530 Jka antigen phenotype is performed within the following profiles:
| Profile | Included Tests |
|---|---|
| Kidd System |
0530 Jka 0531 Jkb |
|
Extensive Phenotype |
0500 Rh D 0501 Rh C 0502 Rh c 0503 Rh E 0504 Rh e 0510 Kell 0511 Cellano 0512 Kpa 0513 Kpb 0520 Fya 0521 Fyb 0530 Jka 0531 Jkb 0535 Lua 0536 Lub 0540 Lea 0541 Leb 0545 P1 0550 M 0551 N 0552 S 0553 s |
References
AABB Technical Manual. 19th edition. Editat per MK Fung, AF Eder, SL Spitalnik, CM Westhoff: AABB 2017
Quality
BST holds ISO 9001, ISO 14001, and OSHAS 18001 quality certifications, as well as the European Excellence 500+ seal. BST is accredited by CAT, JACIE-FACT, FACT-NETCORD, and EFI, and complies with Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) guidelines.